A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)

NCT06657768 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease
Healthy

Interventions

DRUG: LY4006895
DRUG: Placebo

Sponsor

Eli Lilly and Company